ENTITY
Laurus Labs

Laurus Labs (LAURUS IN)

65
Analysis
Health Care • India
Laurus Labs Limited researches, develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India and internationally. It offers APIs for anti-retroviral and hepatitis C; and APIs in oncology and other therapeutic areas. .
more
•08 Dec 2016 08:24

MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...

Logo
4.1k Views
Share
bearish•Laurus Labs
•07 Dec 2016 15:09

Laurus Labs IPO - Fluctuating Margins and Inconsistent Growth Muddle past Record

Laurus labs aims to raise up to US$200m through a mix of primary and secondary issuance of shares.Our fellow insight provider Kemp Dolliver, CFA...

Logo
306 Views
Share
bearish•Laurus Labs
•05 Dec 2016 03:49

Laurus Labs: Final Thoughts

The company has announced a price range of Rs 426 - 428 per share for its listing with bidding set to open on 6 December and closing on 8 December...

Share
bullish•Laurus Labs
•25 Nov 2016 04:24

Laurus Labs IPO Overview

India-based Laurus Labs has filed for a listing on the BSE and NSE, and reportedly plans to raise up to Rs300 crore for debt repayment and general...

Share
•22 Nov 2015 13:18

Profit from India's Rapidly Growing Biotechnology Industry

Now is a strategic time to focus on the upside potential of biotechnology companies in India, as India’s biotechnology industry is projected to...

Share
x